This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Insulin

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

EASD: AFRESA® Phase 3 Data Show Sustained Glycemic Control, Normal Lung Function in Patients over Four Years of Treatment

Posted: Wednesday, October 07, 2009

Long-term study in adults with Type 2 diabetes presented at the 45th annual meeting of the European Association for the Study of Diabetes.

Anakinra Provides Sustained Benefits for Diabetes

Posted: Wednesday, September 30, 2009

Months after withdrawal of the interleukin-1 receptor antagonist (IL-1Ra) anakinra, patients with Type 2 diabetes still show improvements in beta cell function, hemoglobin A1c levels, and markers of systemic inflammation, according to a new published report.

Diabetes History

Posted: Saturday, September 26, 2009

Diabetes treatments are sure much better today than they were hundreds of years of even several years ago. I would have hated to have had diabetes back even several years before, when meters where big and hard to use, and insulin needles were huge sources of pain when injecting. I'd like to take a look back at what diabetes was like many years ago, and tell you just how far diabetes treatments have come!

Insulin-Resistance Variant Identified

Posted: Wednesday, September 16, 2009

An international consortium of scientists has identified a new genetic variant associated with Type 2 diabetes, insulin resistance, and hyperinsulinemia , Dr. Johan Rung Cambridge, UK, and colleagues report.

Insulin or Metformin Does Not Reduce Inflammatory Biomarkers

Posted: Wednesday, September 16, 2009

In patients with recent onset Type 2 diabetes, treatment with insulin or the diabetes drug metformin did not reduce inflammatory biomarkers, such as high-sensitivity C-reactive protein, although the treatment did improve glucose control, according to a study.

New Buccal Insulin Approved by the FDA but with Conditions

Posted: Wednesday, September 16, 2009

Generex Biotechnology Corporation, an innovator for drug delivery for metabolic diseases through the inner lining of the mouth, announced that the U.S. FDA has granted approval for the treatment use of Oral-lyn™ under the FDA’s Treatment Investigational New Drug (IND) program.

Phase II Begins for a New Islet Regeneration Treatment

Posted: Wednesday, September 16, 2009

Exsulin Corporation announces next phase II trial of novel islet regeneration treatment in Type 1 diabetes. Leading diabetes research centers collaborate on new trial designed to further evaluate regeneration treatment for people with Type 1 diabetes.

Computerized Insulin Infusion Works in ICU Patients

Posted: Wednesday, September 16, 2009

A computer-aided insulin infusion protocol maintains glucose control in the ICU as effectively as a strict glycemic control protocol, and both of these methods are more effective than conventional treatment, researchers report.

New Pump CGMS Combo Detects Hypo’s and Turns Off Automatically

Posted: Wednesday, September 09, 2009

This new device, now available in more than 50 countries outside of the United States, can automatically suspend insulin delivery when the device senses that glucose levels have fallen to or below a user-selected threshold.

Insulin-Producing Cells Made from Adult Skin Cells

Posted: Wednesday, September 09, 2009

Using skin cells from people with Type 1 diabetes, researchers were able to produce cells that made insulin in response to changing blood sugar levels.